<?xml version="1.0" encoding="UTF-8" ?>
<modsCollection xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" xmlns:slims="http://slims.web.id" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd">
 <slims:resultInfo>
  <slims:modsResultNum>8</slims:modsResultNum>
  <slims:modsResultPage>1</slims:modsResultPage>
  <slims:modsResultShowed>10</slims:modsResultShowed>
 </slims:resultInfo>
 <mods version="3.3" ID="246303">
  <titleInfo>
   <title>The role of hepatitis C virus NS5A region mutation and SNP IL-28B of host to support successful pegylated interferon and ribavirin treatment in patients with HCV-HIV coinfection:</title>
   <subTitle>A prospective cohort study</subTitle>
  </titleInfo>
  <name type="Personal Name" authority="">
   <namePart>IBRAHIM, Fera</namePart>
   <role>
    <roleTerm type="text">Additional Author</roleTerm>
   </role>
  </name>
  <name type="Personal Name" authority="">
   <namePart>GANI, Rino A</namePart>
   <role>
    <roleTerm type="text">Additional Author</roleTerm>
   </role>
  </name>
  <name type="Personal Name" authority="">
   <namePart>NAFRIALDI</namePart>
   <role>
    <roleTerm type="text">Additional Author</roleTerm>
   </role>
  </name>
  <name type="Personal Name" authority="">
   <namePart>IMMANUEL, Suzanna</namePart>
   <role>
    <roleTerm type="text">Additional Author</roleTerm>
   </role>
  </name>
  <name type="Personal Name" authority="">
   <namePart>DJAUZI, Samsuridjal</namePart>
   <role>
    <roleTerm type="text">Additional Author</roleTerm>
   </role>
  </name>
  <name type="Personal Name" authority="">
   <namePart>KURNIAWAN, Juferdy</namePart>
   <role>
    <roleTerm type="text">Primary Author</roleTerm>
   </role>
  </name>
  <name type="Personal Name" authority="">
   <namePart>HARIMURTI. Kuntjoro</namePart>
   <role>
    <roleTerm type="text">Additional Author</roleTerm>
   </role>
  </name>
  <typeOfResource collection="yes">mixed material</typeOfResource>
  <identifier type="isbn">01259326</identifier>
  <originInfo>
   <place>
    <placeTerm type="text">Jakarta</placeTerm>
    <publisher>Department of Internal Medicine, Faculty of Medicine Universitas Indonesia - Cipto Mangunkusumo Hospital</publisher>
    <dateIssued>2019</dateIssued>
   </place>
  </originInfo>
 </mods>
 <mods version="3.3" ID="243893">
  <titleInfo>
   <title>Safety and efficacy of NC120 for improving lipid profile :</title>
   <subTitle>A double blind randomized controlled trial</subTitle>
  </titleInfo>
  <name type="Personal Name" authority="">
   <namePart>SETIAWATI, Arini</namePart>
   <role>
    <roleTerm type="text">Additional Author</roleTerm>
   </role>
  </name>
  <name type="Personal Name" authority="">
   <namePart>NAFRIALDI</namePart>
   <role>
    <roleTerm type="text">Primary Author</roleTerm>
   </role>
  </name>
  <name type="Personal Name" authority="">
   <namePart>SUYATNA, Frans D.</namePart>
   <role>
    <roleTerm type="text">Additional Author</roleTerm>
   </role>
  </name>
  <name type="Personal Name" authority="">
   <namePart>HUDYONO, Johannes</namePart>
   <role>
    <roleTerm type="text">Additional Author</roleTerm>
   </role>
  </name>
  <typeOfResource collection="yes">mixed material</typeOfResource>
  <identifier type="isbn">01259326</identifier>
  <originInfo>
   <place>
    <placeTerm type="text">Jakarta</placeTerm>
    <publisher>Perhimpunan Dokter Spesialis Penyait Dalam Indonesa</publisher>
    <dateIssued>2019</dateIssued>
   </place>
  </originInfo>
 </mods>
 <mods version="3.3" ID="56900">
  <titleInfo>
   <title>Co-administration of ritonavir and primaquine decreases plasma cconcentrastion of primaquine :</title>
  </titleInfo>
  <name type="Personal Name" authority="">
   <namePart>SETIABUDY, Rianto</namePart>
   <role>
    <roleTerm type="text">Additional Author</roleTerm>
   </role>
  </name>
  <name type="Personal Name" authority="">
   <namePart>SOETIKNO, Vivian</namePart>
   <role>
    <roleTerm type="text">Additional Author</roleTerm>
   </role>
  </name>
  <name type="Personal Name" authority="">
   <namePart>NAFRIALDI</namePart>
   <role>
    <roleTerm type="text">Additional Author</roleTerm>
   </role>
  </name>
  <name type="Personal Name" authority="">
   <namePart>SUYATNA, Frans D.</namePart>
   <role>
    <roleTerm type="text">Additional Author</roleTerm>
   </role>
  </name>
  <name type="Personal Name" authority="">
   <namePart>LOUISA, Melva</namePart>
   <role>
    <roleTerm type="text">Primary Author</roleTerm>
   </role>
  </name>
  <typeOfResource collection="yes">mixed material</typeOfResource>
  <identifier type="isbn">01259326</identifier>
  <originInfo>
   <place>
    <placeTerm type="text">Jakarta</placeTerm>
    <publisher>Interna</publisher>
    <dateIssued>2013</dateIssued>
   </place>
  </originInfo>
 </mods>
 <mods version="3.3" ID="57124">
  <titleInfo>
   <title>Influence of rifampicin on nevirapine plasma concentrations in HIV-TB coinfected patients</title>
  </titleInfo>
  <name type="Personal Name" authority="">
   <namePart>NAFRIALDI</namePart>
   <role>
    <roleTerm type="text">Primary Author</roleTerm>
   </role>
  </name>
  <name type="Personal Name" authority="">
   <namePart>NUGROHO, Agus W.</namePart>
   <role>
    <roleTerm type="text">Additional Author</roleTerm>
   </role>
  </name>
  <name type="Personal Name" authority="">
   <namePart>YUNIHASTUTI, Evy</namePart>
   <role>
    <roleTerm type="text">Additional Author</roleTerm>
   </role>
  </name>
  <name type="Personal Name" authority="">
   <namePart>WIRIA, Meta S.S.</namePart>
   <role>
    <roleTerm type="text">Additional Author</roleTerm>
   </role>
  </name>
  <typeOfResource collection="yes">mixed material</typeOfResource>
  <identifier type="isbn">01259326</identifier>
  <originInfo>
   <place>
    <placeTerm type="text">Jakarta</placeTerm>
    <publisher>Interna Publishing</publisher>
    <dateIssued>2012</dateIssued>
   </place>
  </originInfo>
 </mods>
 <mods version="3.3" ID="64491">
  <titleInfo>
   <title>An observational study to evaluate the safety and efficacy of telbivudine in adults with chronic </title>
  </titleInfo>
  <name type="Personal Name" authority="">
   <namePart>NAFRIALDI</namePart>
   <role>
    <roleTerm type="text">Additional Author</roleTerm>
   </role>
  </name>
  <name type="Personal Name" authority="">
   <namePart>LESMANA, Laurentius A.</namePart>
   <role>
    <roleTerm type="text">Additional Author</roleTerm>
   </role>
  </name>
  <name type="Personal Name" authority="">
   <namePart>HELYANNA</namePart>
   <role>
    <roleTerm type="text">Additional Author</roleTerm>
   </role>
  </name>
  <name type="Personal Name" authority="">
   <namePart>SULAIMAN, Ali</namePart>
   <role>
    <roleTerm type="text">Primary Author</roleTerm>
   </role>
  </name>
  <typeOfResource collection="yes">mixed material</typeOfResource>
  <identifier type="isbn">01259326</identifier>
  <originInfo>
   <place>
    <placeTerm type="text">Jakarta</placeTerm>
    <publisher>Interna Publishing</publisher>
    <dateIssued>2014</dateIssued>
   </place>
  </originInfo>
 </mods>
 <mods version="3.3" ID="226754">
  <titleInfo>
   <title>Efficacy and safety of pioglitazone in type 2 diabetes mellitus :</title>
  </titleInfo>
  <name type="Personal Name" authority="">
   <namePart>NAFRIALDI</namePart>
   <role>
    <roleTerm type="text">Primary Author</roleTerm>
   </role>
  </name>
  <typeOfResource collection="yes">mixed material</typeOfResource>
  <identifier type="isbn">01259326</identifier>
  <originInfo>
   <place>
    <placeTerm type="text">Jakarta</placeTerm>
    <publisher>FK-Universitas Indonesia</publisher>
    <dateIssued>2012</dateIssued>
   </place>
  </originInfo>
 </mods>
 <mods version="3.3" ID="226770">
  <titleInfo>
   <title>Current status of phase i clinical trials in Asia :</title>
  </titleInfo>
  <name type="Personal Name" authority="">
   <namePart>SETIABUDY, Rianto</namePart>
   <role>
    <roleTerm type="text">Additional Author</roleTerm>
   </role>
  </name>
  <name type="Personal Name" authority="">
   <namePart>NAFRIALDI</namePart>
   <role>
    <roleTerm type="text">Additional Author</roleTerm>
   </role>
  </name>
  <name type="Personal Name" authority="">
   <namePart>TAKEUCHI, Masahiro</namePart>
   <role>
    <roleTerm type="text">Additional Author</roleTerm>
   </role>
  </name>
  <name type="Personal Name" authority="">
   <namePart>TAKEUCHI, Madoka</namePart>
   <role>
    <roleTerm type="text">Additional Author</roleTerm>
   </role>
  </name>
  <name type="Personal Name" authority="">
   <namePart>LOUISA, Melva</namePart>
   <role>
    <roleTerm type="text">Primary Author</roleTerm>
   </role>
  </name>
  <typeOfResource collection="yes">mixed material</typeOfResource>
  <identifier type="isbn">01259326</identifier>
  <originInfo>
   <place>
    <placeTerm type="text">Jakarta</placeTerm>
    <publisher>FK-Universitas Indonesia</publisher>
    <dateIssued>2012</dateIssued>
   </place>
  </originInfo>
 </mods>
 <mods version="3.3" ID="235860">
  <titleInfo>
   <title>A clinical trial on biological half life of bioactive protein from lumbricus rubellus, DLBS1033 in healthy volunteers</title>
  </titleInfo>
  <name type="Personal Name" authority="">
   <namePart>NAFRIALDI</namePart>
   <role>
    <roleTerm type="text">Additional Author</roleTerm>
   </role>
  </name>
  <name type="Personal Name" authority="">
   <namePart>SETIABUDY, Rahajuningsih D</namePart>
   <role>
    <roleTerm type="text">Additional Author</roleTerm>
   </role>
  </name>
  <name type="Personal Name" authority="">
   <namePart>GAYATRI, Anggi</namePart>
   <role>
    <roleTerm type="text">Primary Author</roleTerm>
   </role>
  </name>
  <typeOfResource collection="yes">mixed material</typeOfResource>
  <identifier type="isbn">01259326</identifier>
  <originInfo>
   <place>
    <placeTerm type="text">Jakarta</placeTerm>
    <publisher>Faculty of Medicine, UI</publisher>
    <dateIssued>2018</dateIssued>
   </place>
  </originInfo>
 </mods>
</modsCollection>
